Exact Sciences Corp
(NAS:EXAS)
$
54.33
-0.39 (-0.71%)
Market Cap: 10.06 Bil
Enterprise Value: 11.87 Bil
PE Ratio: 0
PB Ratio: 3.13
GF Score: 80/100 Exact Sciences Corp at BTIG Virtual MedTech, Digital Health, Life Sciences, and Diagnostic Tools Conference Transcript
Feb 18, 2021 / 03:30PM GMT
Release Date Price:
$141.65
(+0.47%)
Mark Anthony Massaro
BTIG, LLC, Research Division - MD & Life Science & Diagnostic Tools Analyst
All right. Good morning, everyone. Thank you very much for joining the BTIG MedTech, Diagnostics, Digital Health and Tools Conference. I'm joined with Jeff Elliott, the company's Chief Financial Officer of Exact Sciences, and I have a virtual snowbird in my back. And so hopefully, next year, we can all get on the slopes. Jeff, thanks so much for joining.
Jeffrey T. Elliott
Exact Sciences Corporation - CFO
Good morning, Mark. Thanks for having us.
Questions & Answers
Mark Anthony Massaro
BTIG, LLC, Research Division - MD & Life Science & Diagnostic Tools Analyst
Terrific. So you guys recently had your earnings call, a really solid Q4, beating my and Street expectations. Cologuard screening revenue came in at $250 million. That was up 16% sequentially, 9% year-over-year even despite COVID. I guess can you just walk us through what the key drivers of growth were in Q4? And I'm curious if you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot